Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: bentway who wrote (615796)	6/11/2011 5:03:46 PM
From: longnshort	1 Recommendation Read Replies (1) \| Respond to of 1579932

Regarding that Weiner freak, there is suspicion that he converted from Judaism to Islam to marry his Muslim wife. barracknow.blogspot.com If so, under the tenets of Islam Weiner can treat his wife like an object. As an object under man's control, a wife doesn't have a say in the matter. She must obey or be punished according to Sharia Law.

To: bentway who wrote (615796)	6/14/2011 12:50:54 AM
From: TimF	Respond to of 1579932

Pointing to harm from early or faulty drug approval and use is not enough to make an argument against streamlining the drug approval process. Yes if you approve drugs with less time and expense some people will be harmed or killed, who might not have been without the use of the drug. OTOH people also die or suffer because drugs that could help them are not approved, or not even developed in the first place because of the large cost to develop and test new drugs.

To: bentway who wrote (615796)	6/14/2011 12:51:37 AM
From: TimF	Read Replies (1) \| Respond to of 1579932

Pointing to harm from early or faulty drug approval and use is not enough to make an argument against streamlining the drug approval process. Yes if you approve drugs with less time and expense some people will be harmed or killed, who might not have been without the use of the drug. OTOH people also die or suffer because drugs that could help them are not approved, or not even developed in the first place because of the large cost to develop and test new drugs.